SCHEMBL7051532

SCHEMBL7051532

CCOC(=O)COc1cccc2c1CC[C@](O)(CO)C2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 1/20 0.52
PTGER3 P43115 1/20 0.52
PTGIR P43119 1/20 0.52
PTGDR Q13258 1/20 0.52
USP2 O75604 1/20 0.42
ABCB1 P08183 1/20 0.40
KMT2A Q03164 3/20 0.39
POLB P06746 2/20 0.39
MEN1 O00255 2/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
LMNA P02545 2/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPT P10636 2/20 0.39
HPGD P15428 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
PTPN1 P18031 1/20 0.39
S1PR4 O95977 1/20 0.39
ITGA4 P13612 1/20 0.39
S1PR1 P21453 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9017289 0.86 PTGER1 (0.46) PTGER1PTGER3PTGIRPTGDRUSP2
SCHEMBL9017285 0.85 PTGER1 (0.45) PTGER1PTGER3PTGIRPTGDRUSP2
SCHEMBL7778523 0.82 PTGIR (0.80) PTGER1PTGER3PTGIRPTGDRUSP2
SCHEMBL7778514 0.82 PTGIR (0.80) PTGER1PTGER3PTGIRPTGDRUSP2
SCHEMBL7776656 0.82 PTGIR (0.80) PTGER1PTGER3PTGIRPTGDRUSP2
SCHEMBL8485899 0.81 PTGIR (0.67) PTGER1PTGER3PTGIRPTGDRUSP2
SCHEMBL7050841 0.80 PTGIR (0.69) PTGER1PTGER3PTGIRPTGDRUSP2
SCHEMBL2876699 0.79 RXRA (0.54) USP2ABCB1KMT2AMEN1SMN1; SMN2
SCHEMBL7153256 0.79 PTGIR (0.61) PTGER1PTGER3PTGIRPTGDRUSP2
SCHEMBL7748560 0.78 PTGIR (0.66) PTGER1PTGER3PTGIRPTGDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042277-B1 NAPHTHALENE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2003-04-23 EP disclosed
US-6303649-B1 FOR THERAPY AND PROPHYLAXIS OF ARTERIAL OBSTRUCTION, CEREBROVASCULAR DISEASE, HEPATIC CIRRHOSIS, ARTERIOSCLEROSIS, ISCHEMIC HEART DISEASE, RESTENOSIS, ISCHEMIC COMPLICATIONS AFTER CORONARY ANGIOPLASTY, HYPERTENSION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-10-16 US disclosed
EP-1042277-A1 NAPHTHALENE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-10-11 EP disclosed
WO-1999032435-A1 NAPHTHALENE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-07-01 WO disclosed